The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1436-1442.e2 , June 2009

Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery

  • Jan Fräßdorf, MD

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • Andreas Borowski, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • Dirk Ebel, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • Department of Anesthesiology, Slingeland Ziekenhuis, Doetinchem, The Netherlands
    • ,
  • Peter Feindt, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • Manuel Hermes, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • Thomas Meemann, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • René Weber, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • ,
  • Jost Müllenheim, MD, DEAA

      Affiliations

    • Department of Anesthesiology, South Tyneside District Hospital, South Shields, United Kingdom
    • ,
  • Nina C. Weber, PhD

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Benedikt Preckel, MD, MA, DEAA

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • Corresponding Author InformationAddress for reprints: Benedikt Preckel, MD, MA, DEAA, Academic Medical Center, University of Amsterdam, Postbus 22660 H1Z-120, 1100 DD Amsterdam, The Netherlands.
    • ,
  • Wolfgang Schlack, MD, DEAA

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands

Received 30 January 2008 ,Accepted 6 April 2008.

References 

  1. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth. 2006;20:477–483
  2. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al. Cardiac protection by volatile anaesthetics: a multicenter randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol. 2007;24:323–331
  3. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth. 2006;97:127–136
  4. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B. Mechanisms of xenon and isoflurane induced preconditioning—a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol. 2005;146:445–455
  5. De Hert SG. Anesthetic preconditioning: how important is it in today's cardiac anesthesia. J Cardiothorac Vasc Anesth. 2006;20:473–476
  6. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation. 1999;100:340–344
  7. Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-e and p38 MAPK. Br J Pharmacol. 2005;144:123–132
  8. Julier K, Da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315–1327
  9. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101:299–310
  10. Fryer RM, Schultz JE, Hsu AK, Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol Heart Circ Physiol. 1999;276:H1229–H1235
  11. Fräßdorf J, Ebel D, Weber NC, Preckel B, Schlack W. Sevoflurane induced preconditioning is blocked by aprotinin in rat hearts in vivo. Anesthesiology. 2006;105:A1086
  12. Michel P, Roques F, Nashef SAM. Logistic or additive EuroSCORE for high-risk patients?. Eur J Cardiothorac Surg. 2003;23:684–687
  13. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B. Xenon preconditioning differentially regulates p44/42 MAPK (ERK1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br J Anaesth. 2006;97:298–306
  14. Schlack W, Preckel B, Barthel H, Obal D, Thämer V. Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart. in vivo. Br J Anaesth. 1997;79:88–96
  15. Müllenheim J, Ebel D, Bauer M, Otto F, Heinen A, Fräßdorf J, et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology. 2003;99:624–631
  16. Pouzet B, Lecharny JB, Dehoux M, Paquin S, Kitakaze M, Mantz J, et al. Is there a place for preconditioning during cardiac operations in humans?. Ann Thorac Surg. 2002;73:843–848
  17. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  18. Tomai F, De Paulis R, Penta dP, Colagrande L, Caprara E, Polisca P, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol. 1999;29:1007–1014
  19. Forlani S, Tomai F, De Paulis R, Turani F, Colella D, Nardi P, et al. Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino). 2004;45:117–122
  20. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial. Br J Anaesth. 2007;99:624–631
  21. Tejero-Taldo IM, Gursoy E, Zhao TC, Kukreja RC. Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. J Mol Cell Cardiol. 2002;34:185–195
  22. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002;96:183–188
  23. Kersten JR, Lowe D, Hettrick DA, Pagel PS, Gross GJ, Warltier DC. Glyburide, a KATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg. 1996;83:27–33
  24. Lange M, Smul TM, Blomeyer CA, Redel A, Klotz KN, Roewer N, et al. Role of the beta1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology. 2006;105:503–510
  25. Law-Koune JD, Raynaud C, Liu N, Dubois C, Romano M, Fischler M. Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia. J Cardiothorac Vasc Anesth. 2006;20:484–492
  26. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003;99:314–323
  27. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  28. Selvanayagam JB, Pigott D, Balacumaraswami L, Petersen SE, Neubauer S, Taggart DP. Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;45:629–631
  29. Fellahi JL, Gue X, Richomme X, Monier E, Guillou L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003;99:270–274
  30. Landoni G, Biondi-Zoccai GGL, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2007;21:502–511

 Part of the work has been presented at the ASA meeting 2005, Atlanta, and at the ASA annual meeting 2004, Las Vegas.

 Support was provided from Deutsche Forschungsgemeinschaft (Bonn, Germany, grant No. SCHL 448/5-1), Siemens Medical Solutions Diagnostics (Fernwald, Germany), Abbott GmbH (Wiesbaden, Germany), and institutional resources.

PII: S0022-5223(08)01740-6

doi: 10.1016/j.jtcvs.2008.04.034

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1436-1442.e2 , June 2009

Article Tools

* Image Usage & Resolution